Home / Trastuzumab / Norway
NO ATC L01FD01 · updated 2 Nov 2026
Trastuzumab shortage in Norway
Is there a Trastuzumab shortage in Norway?
Yes. As of 2 Nov 2026, 2 Trastuzumab products are reported short in Norway, the first since 30 Jun 2026. The company estimate for the return is 11 Nov 2026. Main reason: manufacturing problem.
Also short in Spain, Sweden. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Ogivri 150 mg pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg hetteglass | Biosimilar Collaborations Ireland Limited | 30 Jun 2026 | 11 Nov 2026 | Manufacturing problem Produksjonsproblemer |
| NO | Ogivri 420 mg pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg hetteglass | Biosimilar Collaborations Ireland Limited | 23 Sep 2026 | 11 Nov 2026 | Manufacturing problem Produksjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).